SCHEMBL8629006

SCHEMBL8629006

[c]1nnc(-c2cccs2)[nH]1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.43
HPGD P15428 7/20 0.43
ALDH1A1 P00352 7/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
HSD17B10 Q99714 2/20 0.43
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
MAPT P10636 5/20 0.41
MEN1 O00255 4/20 0.41
KMT2A Q03164 4/20 0.41
TDP1 Q9NUW8 2/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
GAA P10253 3/20 0.40
GLA P06280 2/20 0.40
LMNA P02545 2/20 0.40
HTT P42858 2/20 0.40
CYP3A4 P08684 2/20 0.40
CYP2C9 P11712 2/20 0.40
POLB P06746 1/20 0.40
MAPK1 P28482 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1849836 0.68 POLB (0.44) KDM4EHPGDALDH1A1SMN1; SMN2HSD17B10
SCHEMBL4328366 0.68 KDM4E (0.43) KDM4EHPGDALDH1A1SMN1; SMN2HSD17B10
SCHEMBL417270 0.67 GAA (0.49) KDM4EHPGDALDH1A1SMN1; SMN2HSD17B10
SCHEMBL22977618 0.67 KDM4E (0.47) KDM4EHPGDALDH1A1SMN1; SMN2HSD17B10
SCHEMBL8626463 0.67 KDM4E (0.46) KDM4EHPGDALDH1A1SMN1; SMN2HSD17B10
SCHEMBL16291133 0.67 L3MBTL1 (0.57) KDM4EHPGDALDH1A1SMN1; SMN2HSD17B10
SCHEMBL3545 0.67 L3MBTL1 (0.57) KDM4EHPGDALDH1A1SMN1; SMN2HSD17B10
SCHEMBL13977912 0.66 KDM4E (0.52) KDM4EHPGDALDH1A1SMN1; SMN2HSD17B10
Water SCHEMBL5637133 0.65 KDM4E (0.45) KDM4EHPGDALDH1A1SMN1; SMN2HSD17B10
SCHEMBL5788579 0.65 ALDH1A1 (0.52) KDM4EHPGDALDH1A1SMN1; SMN2HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5159070-A Process for the preparation of derivative of 7-[(2-hydroxyimino)-acetamido]-cephalosporanic acid ROUSSEL UCLAF (FR) 1992-10-27 US claimed
US-RE35754-E FOR TREATING BACTERIAL INFECTIONS HOECHST AKTIENGESELLSCHAFT (DE) 1998-03-24 US disclosed
US-5710146-A ANTIBIOTICS FOR BACTERICIDES HOECHST AKTIENGESELLSCHAFT (DE) 1998-01-20 US disclosed
US-5159070-A Process for the preparation of derivative of 7-[(2-hydroxyimino)-acetamido]-cephalosporanic acid ROUSSEL UCLAF (FR) 1992-10-27 US disclosed
US-5089490-A Cephem derivatives HOECHST AKTIENGESELLSCHAFT (DE) 1992-02-18 US disclosed
US-4758556-A Cephem derivatives HOECHST AKTIENGESELLSCHAFT (DE) 1988-07-19 US disclosed
US-4603129-A Cephalosporin derivatives HOECHST AKTIENGESELLSCHAFT (DE) 1986-07-29 US disclosed
US-4470983-A BACTERICIDES, ANTIBIOTICS HOECHST AKTIENGESELLSCHAFT (DE) 1984-09-11 US disclosed
EP-0034760-B1 CEPHALOSPORIN DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND PROCESS FOR THEIR PREPARATION HOECHST AKTIENGESELLSCHAFT (DE) 1984-05-30 EP disclosed
US-4399131-A Cephem derivatives HOECHST AG (DE) 1983-08-16 US disclosed
EP-0002774-B1 PROCESS FOR ACYLATING 7AMINOCEPHEM DERIVATIVES HOECHST AKTIENGESELLSCHAFT (DE) 1981-09-23 EP disclosed
EP-0034760-A1 Cephalosporin derivatives, pharmaceutical compositions and process for their preparation HOECHST AKTIENGESELLSCHAFT (DE) 1981-09-02 EP disclosed
US-4278793-A ANTIBIOTICS, BACTERICIDES HOECHST AKTIENGESELLSCHAFT (DE) 1981-07-14 US disclosed
EP-0002774-A1 Process for acylating 7aminocephem derivatives HOECHST AKTIENGESELLSCHAFT (DE) 1979-07-11 EP disclosed